Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
2,258
Views
2
CrossRef citations to date
0
Altmetric
Review

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines

Lidia Serraa Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USACorrespondence[email protected]
View further author information
,
Markus Knufb Dr. Horst Schmidt Clinic, Children’s Hospital, Wiesbaden, Germany, and Pediatric Infectious Diseases, University Medicine, Mainz, GermanyView further author information
,
Federico Martinón-Torresc Pediatrics Department, Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain;d Genetics, Vaccines and Pediatrics Research Group, University of Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, SpainORCID Iconhttps://orcid.org/0000-0002-9023-581XView further author information
ORCID Icon,
Kevin Yia Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USAView further author information
&
Jamie Findlowe Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Ltd, Tadworth, UKView further author information
Pages 2205-2215 | Received 14 Aug 2020, Accepted 13 Nov 2020, Published online: 19 Feb 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rodolfo Villena, Paula Kriz, Myint Tin Tin Htar, Cindy Burman, Jamie Findlow, Paul Balmer & Luis Jodar. (2023) Real-world impact and effectiveness of MenACWY-TT. Human Vaccines & Immunotherapeutics 19:2.
Read now
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum & Philipp Oster. (2022) Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial. Human Vaccines & Immunotherapeutics 18:5.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.